rs145125791

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004646.4(NPHS1):​c.563A>T​(p.Asn188Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00799 in 1,614,106 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N188N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0060 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0082 ( 66 hom. )

Consequence

NPHS1
NM_004646.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12

Conservation

PhyloP100: 0.514

Publications

12 publications found
Variant links:
Genes affected
NPHS1 (HGNC:7908): (NPHS1 adhesion molecule, nephrin) This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]
NPHS1 Gene-Disease associations (from GenCC):
  • congenital nephrotic syndrome, Finnish type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025585592).
BP6
Variant 19-35850409-T-A is Benign according to our data. Variant chr19-35850409-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 282372.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004646.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS1
NM_004646.4
MANE Select
c.563A>Tp.Asn188Ile
missense
Exon 5 of 29NP_004637.1O60500-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS1
ENST00000378910.10
TSL:1 MANE Select
c.563A>Tp.Asn188Ile
missense
Exon 5 of 29ENSP00000368190.4O60500-1
NPHS1
ENST00000869106.1
c.563A>Tp.Asn188Ile
missense
Exon 5 of 29ENSP00000539165.1
NPHS1
ENST00000353632.6
TSL:5
c.563A>Tp.Asn188Ile
missense
Exon 5 of 28ENSP00000343634.5O60500-2

Frequencies

GnomAD3 genomes
AF:
0.00601
AC:
915
AN:
152152
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00727
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00957
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00605
AC:
1521
AN:
251492
AF XY:
0.00636
show subpopulations
Gnomad AFR exome
AF:
0.00141
Gnomad AMR exome
AF:
0.00428
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00236
Gnomad NFE exome
AF:
0.00927
Gnomad OTH exome
AF:
0.00700
GnomAD4 exome
AF:
0.00820
AC:
11985
AN:
1461836
Hom.:
66
Cov.:
31
AF XY:
0.00806
AC XY:
5865
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.00134
AC:
45
AN:
33480
American (AMR)
AF:
0.00487
AC:
218
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00222
AC:
58
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00539
AC:
465
AN:
86258
European-Finnish (FIN)
AF:
0.00311
AC:
166
AN:
53412
Middle Eastern (MID)
AF:
0.00989
AC:
57
AN:
5766
European-Non Finnish (NFE)
AF:
0.00945
AC:
10503
AN:
1111970
Other (OTH)
AF:
0.00782
AC:
472
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
620
1239
1859
2478
3098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00600
AC:
914
AN:
152270
Hom.:
3
Cov.:
32
AF XY:
0.00623
AC XY:
464
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00178
AC:
74
AN:
41542
American (AMR)
AF:
0.00726
AC:
111
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00643
AC:
31
AN:
4818
European-Finnish (FIN)
AF:
0.00169
AC:
18
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00956
AC:
650
AN:
68018
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00837
Hom.:
1
Bravo
AF:
0.00631
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00977
AC:
84
ExAC
AF:
0.00619
AC:
751
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Finnish congenital nephrotic syndrome (5)
-
-
3
not specified (3)
-
-
2
not provided (2)
-
1
-
Congenital nephrotic syndrome (1)
-
-
1
Focal segmental glomerulosclerosis (1)
-
-
1
NPHS1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
13
DANN
Benign
0.96
DEOGEN2
Benign
0.30
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.79
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
1.7
L
PhyloP100
0.51
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.25
Sift
Benign
0.56
T
Sift4G
Uncertain
0.0020
D
Polyphen
0.57
P
Vest4
0.79
MVP
0.83
MPC
0.44
ClinPred
0.0048
T
GERP RS
2.2
Varity_R
0.22
gMVP
0.53
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145125791; hg19: chr19-36341311; COSMIC: COSV105273982; COSMIC: COSV105273982; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.